Special sessions are very small and specialized events to be held during the conference as a set of oral and poster presentations that are highly specialized in some particular theme or consisting of the works of some particular international project. The goal of special sessions (minimum 4 papers; maximum 9) is to provide a focused discussion on innovative topics. All accepted papers will be published in a special section of the conference proceedings book, under an ISBN reference, and on digital support. All papers presented at the conference venue will be available at the SCITEPRESS Digital Library. SCITEPRESS is a member of CrossRef and every paper is given a DOI (Digital Object Identifier). The proceedings are submitted for indexation by SCOPUS, Google Scholar, The DBLP Computer Science Bibliography, Semantic Scholar, Microsoft Academic, Engineering Index (EI) and Web of Science / Conference Proceedings Citation Index.
Special Session on Non-invasive Diagnosis and Neuro-stimulation in Neurorehabilitation Tasks -
NDNSNT
2021
Paper Submission:
November 26, 2020 (expired)
Authors Notification:
December 14, 2020 (expired)
Camera Ready and Registration:
December 22, 2020 (expired)
Scope
Among the leading causes of disability and high mortality are diseases of the central nervous system that are accompanied by cognitive, sensor, motor and autonomic disorders. For treatment of such diseases pharmacological methods are not always in conformity with the contemporary requirements of efficacy and safety of health care. New technologies for diagnosis and neuroprotection are emerging, based on application of different physical fields for formation of the neuromodulation as well as methods for its visualization. Especially promising is combined application. Participation in this Special Session of scientist, involved in various research directions of diagnosis and neuro-stimulation theory and techniques, will allow formulating new strategies for diagnosis and treatment process, aimed to minimize health risks for each person, based on personalized strategies of prevention and therapy.
Special Session on Dealing with the Change in European Regulations for Medical Devices -
ClinMed
2021
Paper Submission:
November 26, 2020 (expired)
Authors Notification:
December 14, 2020 (expired)
Camera Ready and Registration:
December 22, 2020 (expired)
Scope
The new European regulation (EU MDR 2017/745) will enter into force on May 26, 2021. This new regulation sets forth new, improved rules to strengthen clinical evidence, particularly for high-risk medical devices for which a clinical study is mandatory. Given the wide range of medical devices available on the market and their countless variations in design features, treatment goals and targeted patient groups, setting a single standard study protocol seems unfeasible.This special session will cover efforts to build clinical evidence in accordance with the new regulations. We accept submissions covering all phases of the development cycle of a new medical device, from preliminary study confirming proof of concept to post-market clinical follow-up (real-world data) as well as in silico trials, first survey clinical in humans, medico-economy or usability study.